‘We can’t do it alone’: UCB’s Colin Lake on partnerships, patients and rare diseases
About this episode
Colin Lake discusses UCB's digital strategy and partnerships aimed at improving care for rare disease patients.
Colin Lake, VP and head of digital care transformation, neurology and rare disease at UCB, is passionate about helping patients with rare diseases. He joins Maria Whitman to talk about how UCB has focused on simplifying its digital strategy to address key pain points for rare disease patients. Highlights include: Why partnerships are an important part of this journeyHow a collaboration using ZS’s ZEBRA tool helped UCB move the needle of diagnosisWhy pharma leaders should experiment with...
People in this episode
Host: Maria Whitman
Guest: Colin Lake
Topics covered
- rare diseases
- digital strategy
- patient care
- partnerships
- pharma collaboration
Mentioned in this episode
Organizations: UCB, ZS
Products: ZEBRA
More episodes of Transforming Biopharma
- ‘Everything changes at the same time’: On conversational AI with Veeva’s Arno Sosna
- Cultivating resilience: Building a better supply chain with McKesson’s Ammie McAsey
- ‘The hinge moment’: Envisioning transformation with Amgen’s Alex Koehler
- ‘We’re all tech leaders now’: A conversation with Salesforce’s Kyrsten Musich
- How CRM can help pharma break barriers and transform customer engagement
- Expanding access to cell and gene therapies with McKesson’s Joe DePinto
Explore listener stats, chart rankings, contacts and more on the Transforming Biopharma podcast page.